Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00210041 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma

StatusCompleted
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study Status, Referencesv8
  2. Trial status: Suspended to Completed Study completion date changed from estimate of Sep 2012 to Dec 2012v7 Show 1 more changeShow less
    • Study completion date changed from estimate of Sep 2012 to Dec 2012
  3. Trial status: Recruiting to Suspended Sponsor's reason: interim analysis Primary completion date: Dec 2011 · Secondary endpoints: details revised at 3 of 3 entries · Site details revised at 11 of 11 sitesv6 Show 3 more changesShow less
    • Primary completion date: Dec 2011
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site details revised at 11 of 11 sites
  4. Site contacts updated at 1 of 11 sitesv5
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Site contacts updated at 1 of 11 sitesv3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine whether association Gemcitabine-Cisplatin is effective in the treatment of penis epidermoid carcinoma loco-regionally advanced or metastatic.
Trial Details
NCT Number NCT00210041
Lead Sponsor Institut Claudius Regaud
Conditions Genital Neoplasms, Male
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov